SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-015576
Filing Date
2024-01-25
Accepted
2024-01-25 17:31:01
Documents
19
Period of Report
2024-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d699303d8k.htm   iXBRL 8-K 40775
2 EX-1.1 d699303dex11.htm EX-1.1 40413
3 EX-4.1 d699303dex41.htm EX-4.1 81462
4 EX-4.2 d699303dex42.htm EX-4.2 85747
5 EX-4.3 d699303dex43.htm EX-4.3 7972
6 EX-5.1 d699303dex51.htm EX-5.1 13994
7 EX-10.1 d699303dex101.htm EX-10.1 213692
11 GRAPHIC g699303g0125141403439.jpg GRAPHIC 2537
  Complete submission text file 0001193125-24-015576.txt   749475

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA awh-20240124.xsd EX-101.SCH 2856
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE awh-20240124_lab.xml EX-101.LAB 18757
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE awh-20240124_pre.xml EX-101.PRE 11715
13 EXTRACTED XBRL INSTANCE DOCUMENT d699303d8k_htm.xml XML 3577
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 24563358
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)